Resveratrol alleviates diabetic cardiomyopathy in rats by improving mitochondrial function through PGC-1α deacetylation

Aug 4, 2017Acta pharmacologica Sinica

Resveratrol may reduce diabetic heart damage in rats by improving energy production in heart cells

AI simplified

Abstract

Resveratrol (50 mg·kg·d) significantly improved cardiac function in diabetic rats over 16 weeks.

  • Cardiac function improvements included increased ejection fraction, fraction shortening, and E/A ratio, along with reduced pro-hypertrophic marker levels.
  • Resveratrol administration enhanced mitochondrial function, indicated by increased manganese superoxide dismutase activity, ATP content, mitochondrial DNA copy number, and mitochondrial membrane potential.
  • Resveratrol decreased levels of malondialdehyde and uncoupling protein 2 in diabetic hearts.
  • Activation of SIRT1 and increased PGC-1α deacetylation were observed following resveratrol treatment.
  • In vitro studies showed that resveratrol's protective effects on H9c2 cells under high glucose conditions were dependent on SIRT1 activity.

AI simplified

Full Text

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free